Skip to main content

Public comment

What's happening in Public Comment

Special public comment for Revised Bylaws and Management and Membership Policies was open from October 25 through November 8. View feedback.

Summer 2024 public comment was open from July 31 through September 24, 2024. View feedback.

Public comment response submissions will be moderated by the end of the next business day.

Public comment is an essential part of the policy development process that occurs twice each year. The OPTN policy development process incorporates public comment feedback on policy and bylaws proposals before they go to the OPTN board of directors for approval. All interested individuals are welcome to participate, especially transplant candidates, who are most affected by policies. Transplant professionals are encouraged to provide comment about potential financial impact a proposal could have on their organization.

To encourage public participation and promote transparency, this site publishes submitted comments.

1
step 1 arrow

Gather ideas

2
step 2 arrow

Develop proposals

3
step 3 arrow

Public comment

4
step 4 arrow

Finalize and approve

5
step 5 arrow

Implement and evaluate

Public Comment Proposals

OPTN Policy (PDF) Standards Archives

There are no open Public Comment Proposals at this time.

View other policy projects

Proposals in Committee Review

OPTN Policy (PDF) Standards Archives
Update Criteria for Post-Transplant Graft Survival Metrics Membership and Professional Standards (MPSC)
Revised Bylaws and Management and Membership Policies Executive
Continuous Distribution of Kidneys Update, Summer 2024 Kidney Transplantation
Efficiency and Utilization in Kidney and Pancreas Continuous Distribution Request for Feedback Kidney Transplantation and Pancreas Transplantation
Continuous Distribution of Pancreata Update, Summer 2024 Pancreas Transplantation
Continuous Distribution of Livers & Intestines Update, Summer 2024 Liver and Intestinal Organ Transplantation
Continuous Distribution of Hearts Update, Summer 2024 Heart Transplantation
Update Histocompatibility Bylaws Histocompatibility
Require Reporting of HLA Critical Discrepancies and Crossmatching Events to the OPTN Histocompatibility
Concepts for a Collaborative Approach to Living Donor Data Collection Living Donor
Revise Conditions for Access to the OPTN Computer System Network Operations Oversight Committee
Promote Efficiency of Lung Donor Testing Lung Transplantation
Update on Continuous Distribution of Livers and Intestines, 2023 Liver and Intestinal Organ Transplantation
Clarification of OPO and Living Donor Recovery Hospital Requirements for Organ Donors with HIV Positive Test Results Ad Hoc Disease Transmission Advisory (DTAC)
Reinstatement of Updates to Candidate Data During the COVID-19 Emergency Executive
Continuous Distribution of Hearts Heart Transplantation
Update on Continuous Distribution of Hearts Heart Transplantation
Update on Continuous Distribution of Livers and Intestines Liver and Intestinal Organ Transplantation
Ethical Evaluation of Multiple Listing Ethics
​​Concepts for Modifying Multi-Organ Policies​ Ad Hoc Multi Organ
Identify Priority Shares in Kidney Multi-Organ Allocation Ad Hoc Multi Organ
Continuous Distribution of Kidneys and Pancreata Committee Update Kidney Transplantation and Pancreas Transplantation
Require Human Leukocyte Antigen (HLA) Confirmatory Typing for Deceased Donors Histocompatibility
Continuous Distribution of Kidneys and Pancreata Update Kidney Transplantation and Pancreas Transplantation
Continuous Distribution of Livers and Intestines Concept Paper Liver and Intestinal Organ Transplantation
Redefining Provisional Yes and the Approach to Organ Offer and Acceptance Operations and Safety (OSC)
Optimizing Usage of Kidney Offer Filters Operations and Safety (OSC)
Redesign Map of OPTN Regions Executive
Proposal to Revise the OPTN Charter Executive
Continuous Distribution of Kidneys & Pancreata Request for Feedback Kidney Transplantation and Pancreas Transplantation
Update on OPTN Regional Review Project Executive
Update on Continuous Distribution of Kidneys and Pancreata Kidney Transplantation and Pancreas Transplantation
Reassess Inclusion of Race in Estimated Glomerular Filtration Rate (eGFR) Equation Minority Affairs and Kidney Transplantation
Develop Measures for Primary Graft Dysfunction in Hearts Heart Transplantation
Update Transplant Program Key Personnel Training and Experience Requirements Membership and Professional Standards (MPSC)
Update on the Continuous Distribution of Organs Project Lung Transplantation
Data Collection to Assess Socioeconomic Status and Access to Transplant Minority Affairs
Measuring Transplant Outcomes by Collecting Data on Children Born to Uterus Recipients Vascularized Composite Allograft (VCA) Transplantation
Data collection to evaluate the logistical impact of broader distribution Operations and Safety (OSC)
Continuous distribution of lungs concept paper Lung Transplantation and Thoracic Organ Transplantation
MELD exception scores during NLRB transition Executive
Concept paper on improving the OPTN UNOS committee structure Executive
Concept paper on expedited organ placement Organ Procurement Organization (OPO)
Deceased donor initiated KPD chains Kidney Transplantation
Broaden pancreas allocation across compatible ABO blood types Pancreas Transplantation

OPTN Standards for Public Comment

  • Be respectful. Personal attacks, profanity, and aggressive behavior are prohibited. Instigating arguments in a disrespectful way is also prohibited.
  • No patient identified, peer review privileged, or other confidential information
  • No vulgar, obscene, or profane language, or “hate speech,” which is defined as language intended to foster hatred against individuals or groups based on race, religion, gender, sexual preference, place of national origin, or other improper classification
  • No language that would violate the law if published
  • No suggestion or encouragement of illegal activity
  • No seeking of medical advice
  • No solicitations or comments that promote a particular service or product. This includes solicitations for commercial activity within ANY industry, transplant-related or not. This does not include solicitation of support for or against a specific OPTN proposal.

Any solicitations for directed organ donation to a specific individual will not be posted.